Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24019545

Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2013 Oct 20
First author
Motzer RJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2013 Oct 20;31(30):3746-8. doi: 10.1200/JCO.2013.51.4869.
    note
    Source null
    related pmid
    24019543
    relationship
    Comment in

Authors and identifiers

  1. name
    Motzer RJ
    type
    Author
  2. name
    Nosov D
    type
    Author
  3. name
    Eisen T
    type
    Author
  4. name
    Bondarenko I
    type
    Author
  5. name
    Lesovoy V
    type
    Author
  6. name
    Lipatov O
    type
    Author
  7. name
    Tomczak P
    type
    Author
  8. name
    Lyulko O
    type
    Author
  9. name
    Alyasova A
    type
    Author
  10. name
    Harza M
    type
    Author
  11. name
    Kogan M
    type
    Author
  12. name
    Alekseev BY
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Motzer RJ
    type
    Author
  2. name
    Nosov D
    type
    Author
  3. name
    Eisen T
    type
    Author
  4. name
    Bondarenko I
    type
    Author
  5. name
    Lesovoy V
    type
    Author
  6. name
    Lipatov O
    type
    Author
  7. name
    Tomczak P
    type
    Author
  8. name
    Lyulko O
    type
    Author
  9. name
    Alyasova A
    type
    Author
  10. name
    Harza M
    type
    Author
  11. name
    Kogan M
    type
    Author
  12. name
    Alekseev BY
    type
    Author
bibliography ids
  1. nci-bib-4f75cbb75479db2311a37eb2
book metadata
content sha256
b71b626006064b24818b7841c9a6fceab0f343c7b099c8b7d9282ec992251a46
document type
citation
dois
  1. 10.1200/JCO.2012.47.4940
electronic publication date
display
2013 Sep 9
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:24019545
immutable id
pubmed:24019545@b71b626006064b24818b7841c9a6fceab0f343c7b099c8b7d9282ec992251a46
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
30
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3791-9
volume
31
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2013 Oct 20;31(30):3746-8. doi: 10.1200/JCO.2013.51.4869.
    note
    Source null
    related pmid
    24019543
    relationship
    Comment in
outcomes validated
false
pmid
24019545
provenance
batch id
0a08f044391426feb8ef
provider
NCBI PubMed ESummary
record sha256
1a463f0ca79c5e82ce06a82ba296ece67568a56743982f3948740de09c74ff6f
response sha256
d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
retrieved at
2026-09-09T23:46:57.614689+00:00
publication date
display
2013 Oct 20
precision
day
year
2013
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24019545/
title
Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial.

Preserved source evidence · Not medical advice